🔗 Permalink

Inventor profile of:

Eric A. Johnson

City:

Madison, Wisconsin

Country:

United States

Published Applications:

Last publication date:

2024-05-02

Top Assignees for applications by Eric A. Johnson

The entities that hold a legal rights for patent applications filed by inventor Johnson Eric A.:

WISCONSIN ALUMNI RESEARCH FOUNDATION 15 Madison, WI United States
The Medical College of Wisconsin, Inc. 2 Milwaukee, WI United States
CELLSNAP, LLC 2 Madison, WI United States
The Regents of the University of California 2 Oakland, CA United States
The MCW Research Foundation, Incorporated 1 Milwaukee, WI United States
WISONSIN ALUMNI RESEARCH FOUNDATION 1 Madison, WI United States
Gary E. Borodic 1 Cambridge, MA United States
The Scripps Research Institute 1 La Jolla, CA United States
IGENE BIOTECHNOLOGY, INC. 1 Columbia, MD United States

Recent patent applications by Johnson Eric A.

Eric A. Johnson from Madison, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-02

US20240139332A1

Human necessities

Modified Clostridial Neurotoxins as Vaccine and Conjugate Vaccine Platforms

#2 | 2021-09-30

US20210300970A1

Chemistry; metallurgy

COVID-19 VACCINE

#3 | 2019-10-24

US20190321453A1

Human necessities

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

#4 | 2018-07-12

US20180193435A1

Human necessities

Hybrid neurotoxins and uses thereof

#5 | 2018-05-03

US20180117129A1

Human necessities

Neurotoxins and uses thereof

#6 | 2017-10-05

US20170281737A1

Human necessities

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

#7 | 2016-12-15

US20160362671A1

Chemistry; metallurgy

PLASMID-ENCODED NEUROTOXIN GENES IN CLOSTRIDIUM BOTULINUM SEROTYPE A SUBTYPES

#8 | 2016-12-15

US20160361429A1

Human necessities

Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

#9 | 2014-09-11

US20140255376A1

Human necessities

Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

#10 | 2014-04-17

US20140106458A1

Chemistry; metallurgy

Conjugative plasmids and methods of use thereof

#11 | 2014-03-06

US20140065668A1

Chemistry; metallurgy

Plasmid-encoded neurotoxin genes in serotype A subtypes

#12 | 2012-06-28

US20120164657A1

Chemistry; metallurgy

Method of detecting botulinum neurotoxin and antibodies that neutralize botulinum neurotoxin action

#13 | 2011-07-28

US20110183357A1

Chemistry; metallurgy

Device and methods for liquid crystal-based bioagent detection

#14 | 2011-07-14

US20110171734A1

Chemistry; metallurgy

CONJUGATIVE PLASMIDS AND METHODS OF USE THEREOF

#15 | 2011-07-14

US20110171226A1

Chemistry; metallurgy

Subtype of neurotoxin type A and uses thereof

#16 | 2010-12-09

US20100311118A1

Chemistry; metallurgy

Plasmid-encoded neurotoxin genes in serotype A subtypes

#17 | 2010-05-25

US8458019

Processes for in vivo production of astaxanthin and phaffia rhodozyma yeast of enhanced astaxanthin content

#18 | 2010-05-06

US20100112149A1

Chemistry; metallurgy

Nontoxigenic strains and uses thereof

#19 | 2009-07-16

US20090182123A1

Chemistry; metallurgy

Method of preparing botulinum neurotoxin type E light chain

#20 | 2009-01-15

US20090017495A1

Chemistry; metallurgy

-derived vaccine and therapy against botulism

#21 | 2007-10-04

US20070231832A1

Chemistry; metallurgy

Device and methods for liquid crystal-based bioagent detection

#22 | 2007-03-15

US20070059326A1

Chemistry; metallurgy

Escherichia coli-derived vaccine and therapy against botulism

#23 | 2006-11-16

US20060258847A1

Chemistry; metallurgy

Method for preparing botulinum neurotoxin type A light chain

InventorID:

676922 ⎘